Target
Complement factor D
Ligand
BDBM354141
Substrate
n/a
Meas. Tech.
Factor D Assay
IC50
5050±n/a nM
Citation
 Gadhachanda, VRWang, QPais, GHashimoto, AChen, DWang, XAgarwal, ADeshpande, MWiles, JAPhadke, AS Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders US Patent  US9796741 Publication Date 10/24/2017 
Target
Name:
Complement factor D
Synonyms:
Adipsin | C3 convertase activator | CFAD_HUMAN | CFD | DF | PFD | Properdin factor D
Type:
Protein
Mol. Mass.:
27039.19
Organism:
Homo sapiens (Human)
Description:
P00746
Residue:
253
Sequence:
MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA
  
Inhibitor
Name:
BDBM354141
Synonyms:
(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N-(2- ethyl-3-oxoisoindolin- 5-yl)-4- fluoropyrrolidine-2- carboxamide | US10287301, Compound 49 | US10822352, Comp No. 49 | US9796741, cmp No. 49
Type:
Small organic molecule
Emp. Form.:
C31H29FN6O4
Mol. Mass.:
568.5982
SMILES:
CCN1Cc2ccc(NC(=O)[C@@H]3C[C@@H](F)CN3C(=O)Cn3cc(C(C)=O)c4cc(ccc34)-c3ccnnc3)cc2C1=O |r|
Structure:
Search PDB for entries with ligand similarity: